152 related articles for article (PubMed ID: 33663112)
1. Novel oxidative stress-related prognostic biomarkers for melanoma associated with tumor metastasis.
Wu X; Zhao J
Medicine (Baltimore); 2021 Feb; 100(8):e24866. PubMed ID: 33663112
[TBL] [Abstract][Full Text] [Related]
2. Identification of hub prognosis-associated oxidative stress genes in skin cutaneous melanoma using integrated bioinformatic analysis.
Ren TY; Zhang YX; Hu W
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2927-2940. PubMed ID: 33877656
[TBL] [Abstract][Full Text] [Related]
3. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma.
Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z
Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671
[TBL] [Abstract][Full Text] [Related]
4. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
Liu X; Wang J
Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
6. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
7. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
[TBL] [Abstract][Full Text] [Related]
8. Construction of autophagy prognostic signature and analysis of prospective molecular mechanisms in skin cutaneous melanoma patients.
Liao S; He J; Liu C; Zhang Z; Liao H; Liao Z; Yu C; Guan J; Mo H; Yuan Z; Liang T; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
Medicine (Baltimore); 2021 Jun; 100(22):e26219. PubMed ID: 34087900
[TBL] [Abstract][Full Text] [Related]
9. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
Fan Y; Liang X; Yu D
Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and immune-related value of STK17B in skin cutaneous melanoma.
Shi X; Zhou Q; Huang B; Xia S; Jiang Y; Fang S; Lin J
PLoS One; 2022; 17(2):e0263311. PubMed ID: 35171924
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of an oxidative stress-associated prognostic risk model for melanoma.
Yang Y; Long X; Li K; Li G; Yu X; Wen P; Luo J; Tian X; Zhao J
PeerJ; 2021; 9():e11258. PubMed ID: 33976978
[TBL] [Abstract][Full Text] [Related]
12. Prognostic score model-based signature genes for predicting the prognosis of metastatic skin cutaneous melanoma.
Wang J
Math Biosci Eng; 2021 Jun; 18(5):5125-5145. PubMed ID: 34517481
[TBL] [Abstract][Full Text] [Related]
13. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
Zhao S; Zhu Y; Liu H; He X; Xie J
J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
[TBL] [Abstract][Full Text] [Related]
14. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Han W; Huang B; Zhao XY; Shen GL
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
Jiang Y; Zhang C; Zhang J; Han D; Shi X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma.
Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST
J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and immune infiltration in melanoma patients with different mutation burden.
Wang L; Chen F; Liu R; Shi L; Zhao G; Yan Z
BMC Cancer; 2021 Apr; 21(1):379. PubMed ID: 33836680
[TBL] [Abstract][Full Text] [Related]
18. Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.
Zhang E; Chen Y; Bao S; Hou X; Hu J; Mu OYN; Song Y; Shan L
Hum Genomics; 2021 Aug; 15(1):53. PubMed ID: 34384498
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of T-Box Transcription Factor Protein 21 (TBX21) in Skin Cutaneous Melanoma Predicts Better Prognosis: A Study Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Databases.
Zhang X; Wen X; Feng N; Chen A; Yao S; Ding X; Zhang L
Med Sci Monit; 2020 Jun; 26():e923087. PubMed ID: 32561704
[TBL] [Abstract][Full Text] [Related]
20. Systemic Analysis of the Prognosis-Related RNA Alternative Splicing Signals in Melanoma.
Xue D; Cheng P; Jiang J; Ren Y; Wu D; Chen W
Med Sci Monit; 2020 Mar; 26():e921133. PubMed ID: 32199022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
